ResMed Inc. Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount
ResMed Inc. (RSMDF) had Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount of $1.96 million as of 2022-06-30, per its 10-K filed 2022-08-12.
Discontinued › Notes › Leases
us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount · last filed 2022-08-12
- 2022-06-30: Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount $1.96M.
- 2021-06-30: Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount $1.36M.
- 2020-06-30: Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount $1.42M.
| Period end | Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount |
|---|---|
| 2022-06-30 | $1.96M 10-K · filed 2022-08-12 |
| 2021-06-30 | $1.36M 10-K · filed 2021-08-17 |
| 2020-06-30 | $1.42M 10-K · filed 2020-08-13 |